Atossa Therapeutics, Inc. (ATOS)
NASDAQ: ATOS · Real-Time Price · USD
1.200
-0.080 (-6.25%)
Nov 20, 2024, 4:00 PM EST - Market open
Atossa Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
12
Market Cap
150.96M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Nevro | 419.15M |
Nutex Health | 292.00M |
The Joint | 120.80M |
Organigram Holdings | 110.30M |
Fulcrum Therapeutics | 80.87M |
2seventy bio | 45.62M |
EUDA Health Holdings | 3.81M |
ATOS News
- 2 hours ago - Atossa Therapeutics to Present Poster on (Z)-Endoxifen at AACR Special Conference in Cancer Research - GlobeNewsWire
- 1 day ago - Atossa Therapeutics Announces Five Abstracts Highlighting (Z)-Endoxifen Research Accepted for Presentation at the 2024 San Antonio Breast Cancer Symposium - GlobeNewsWire
- 9 days ago - Atossa Therapeutics Announces Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 16 days ago - Atossa Therapeutics Appoints Claudia Lopez, DVM, MSc, as Vice President, Clinical Product Development - GlobeNewsWire
- 17 days ago - Atossa Therapeutics Reports Positive KARISMA-Endoxifen Trial Results: - GlobeNewsWire
- 21 days ago - Atossa Therapeutics Releases Promising Preliminary Analysis Demonstrating (Z)-Endoxifen's Potential to Rapidly Reduce Ki-67 and Tumor Volume in ER+/HER2- Breast Cancer - GlobeNewsWire
- 4 weeks ago - Atossa Therapeutics to Participate in Fireside Chat with Karolinska Institute at BIO-EUROPE 2024 to Discuss a Unique Swedish American Collaboration to Prevent Breast Cancer - GlobeNewsWire
- 5 weeks ago - Atossa Therapeutics to Present at the 2024 Maxim Healthcare Virtual Summit - GlobeNewsWire